Lowest Price Guaranteed
Pages
190
Last Updated
July 2026
View Count
28774
1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Key Questions Answered
1.4. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Chapter Overview
3.2. Introduction to Telemedicine
3.2.1. Store-and-Forward Telemedicine
3.2.2. Real-Time Telemedicine
3.2.3. Telemedicine in Remote Patient Monitoring
3.3. Advantages of Remote Patient Monitoring
3.4. Limitations Associated with Remote Patient Monitoring
3.5. Regulatory Considerations for Remote Patient Monitoring Solutions
3.6. Concluding Remarks
4. MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Remote Patient Monitoring Consultation Tools and Software: Overall Market Landscape
4.2.1. Analysis by Type of Software
4.2.2. Analysis by Purpose of Software
4.2.3. Analysis by Area of Application
4.2.4. Analysis by Therapeutic Area
4.2.5. Analysis by Type of Telemedicine Operation
4.2.6. Analysis by Type of Remote Patient Monitoring Service Offered
4.2.7. Analysis by Type of Business Model
4.3. Remote Patient Monitoring Consultation Tools and Software: Solution Providers Landscape
4.3.1. Analysis by Year of Establishment
4.3.2. Analysis by Company Size
4.3.3. Analysis by Location of Headquarters
5. COMPANY PROFILES
5.1. Chapter Overview
5.2. Players based in North America
5.2.1. BioTelemetry
5.2.1.1. Company Overview
5.2.1.2. Financial Information
5.2.1.3. Software Portfolio
5.2.1.4. Future Outlook
5.2.2. LeewayHertz
5.2.2.1. Company Overview
5.2.2.2. Software Portfolio
5.2.2.3. Future Outlook
5.2.3. Masimo
5.2.3.1. Company Overview
5.2.3.2. Financial Information
5.2.3.3. Software Portfolio
5.2.3.4. Future Outlook
5.3. Players based in Europe
5.3.1. Braster
5.3.1.1. Company Overview
5.3.1.2. Software Portfolio
5.3.1.3. Future Outlook
5.3.2. LifeWatch
5.3.2.1. Company Overview
5.3.2.2. Software Portfolio
5.3.2.3. Future Outlook
5.3.3. Medtronic
5.3.3.1. Company Overview
5.3.3.2. Financial Information
5.3.3.3. Software Portfolio
5.3.3.4. Future Outlook
5.3.4. Siemens Healthineers
5.3.4.1. Company Overview
5.3.4.2. Financial Information
5.3.4.3. Software Portfolio
5.3.4.4. Future Outlook
5.4. Players based in Asia-Pacific
5.4.1. Transtek Medical
5.4.1.1. Company Overview
5.4.1.2. Financial Information
5.4.1.3. Software Portfolio
5.4.1.4. Future Outlook
6. PARTNERSHIPS AND COLLABORATIONS
6.1. Chapter Overview
6.2. Partnership Models
6.3. Remote Patient Monitoring Consultation Tools and Software Providers: Recent Partnerships and Collaborations
6.3.1. Analysis by Year of Partnership
6.3.2. Analysis by Type of Partnership
6.3.2.1. Analysis by Year and Type of Partnership
6.3.2.2. Analysis by Type of Partnership and Company Size
6.3.3. Analysis by Type of Software
6.3.3.1. Analysis by Year of Partnership and Type of Software
6.3.3.2. Analysis by Type of Partnership and Type of Software
6.3.4. Most Active Players: Analysis by Number of Partnerships
6.3.5. Regional Analysis
6.3.5.1. Intercontinental and Intracontinental Agreements
7. FUNDING AND INVESTMENT ANALYSIS
7.1. Chapter Overview
7.2. Types of Funding
7.3. Remote Patient Monitoring Consultation Tools and Software Providers: Funding and Investment Analysis
7.3.1. Analysis by Cumulative Year-wise Trend, 2015 - 2021
7.3.2. Analysis by Amount Invested
7.3.3. Analysis by Type of Funding
7.3.3.1. Analysis by Type of Venture Capital Round
7.3.4. Analysis by Type of Software
7.3.5. Analysis by Focus Area
7.3.6. Analysis by Geography
7.3.7. Most Active Players: Analysis by Number of Instances
7.3.8. Most Active Players: Analysis by Amount Invested
7.3.9. Most Active Investors: Analysis by Number of Instances
7.3.10. Analysis by Year, Amount Invested and Type of Investor
7.4. Concluding Remarks
8. PRODUCT COMPETITIVENESS ANALYSIS
8.1. Chapter Overview
8.2. Methodology
8.3. Assumptions / Key Parameters
8.4. Product Competitiveness: Software as a Service
8.5. Product Competitiveness: Software as a System
9. COST SAVING ANALYSIS
9.1. Chapter Overview
9.2. Key Assumptions and Methodology
9.3. Remote Patient Monitoring Solutions: Overall Cost Saving Potential
9.3.1. Likely Cost Savings in North America, 2021-2035
9.3.2. Likely Cost Savings in Europe, 2021-2035
9.3.3. Likely Cost Savings in Asia, 2021-2035
9.3.4. Likely Cost Savings in Rest of the World, 2021-2035
9.4. Conclusion
10. MARKET FORECAST
10.1. Chapter Overview
10.2. Forecast Methodology and Key Assumptions
10.3. Global Remote Patient Monitoring Consultation Tools and Software Providers Market, 2021-2035
10.4. Remote Patient Monitoring Consultation Tools and Software Providers Market: Distribution by Type of Area of Application
10.4.1. Remote Patient Monitoring Consultation Tools and Software Providers Market for Blood Glucose, 2021-2035
10.4.2. Remote Patient Monitoring Consultation Tools and Software Providers Market for Blood Pressure, 2021-2035
10.4.3. Remote Patient Monitoring Consultation Tools and Software Providers Market for ECG, 2021-2035
10.4.4. Remote Patient Monitoring Consultation Tools and Software Providers Market for Oxygen Saturation, 2021-2035
10.4.5. Remote Patient Monitoring Consultation Tools and Software Providers Market for Respiration Rate, 2021-2035
10.4.6. Remote Patient Monitoring Consultation Tools and Software Providers Market for Body Temperature, 2021-2035
10.4.7. Remote Patient Monitoring Consultation Tools and Software Providers Market for Other Areas of Application, 2021-2035
10.5. Global Remote Patient Monitoring Consultation Tools and Software Providers Market: Distribution by Therapeutic Area
10.5.1. Remote Patient Monitoring Consultation Tools and Software Providers Market for Cardiovascular Disorders, 2021-2035
10.5.2. Remote Patient Monitoring Consultation Tools and Software Providers Market for Infectious Diseases, 2021-2035
10.5.3. Remote Patient Monitoring Consultation Tools and Software Providers Market for Metabolic Disorders, 2021-2035
10.5.4. Remote Patient Monitoring Consultation Tools and Software Providers Market for Oncological Disorders, 2021-2035
10.5.5. Remote Patient Monitoring Consultation Tools and Software Providers Market for Respiratory Disorders, 2021-2035
10.5.6. Remote Patient Monitoring Consultation Tools and Software Providers Market for Other Therapeutic Areas, 2021-2035
10.6. Global Remote Patient Monitoring Consultation Tools and Software Providers Market: Distribution by Purpose of Software
10.6.1. Remote Patient Monitoring Consultation Tools and Software Providers Market for Clinical Studies, 2021-2035
10.6.2. Remote Patient Monitoring Consultation Tools and Software Providers Market for Commercial Purposes, 2021-2035
10.7. Global Remote Patient Monitoring Consultation Tools and Software Providers Market: Distribution by Type of Business Model
10.7.1. Remote Patient Monitoring Consultation Tools and Software Providers Market for B2B, 2021-2035
10.7.2. Remote Patient Monitoring Consultation Tools and Software Providers Market for B2C, 2021-2035
10.8. Global Remote Patient Monitoring Consultation Tools and Software Providers Market: Distribution by Geography
10.8.1. Remote Patient Monitoring Consultation Tools and Software Providers Market in North America, 2021-2035
10.8.2. Remote Patient Monitoring Consultation Tools and Software Providers Market in Europe, 2021-2035
10.8.3. Remote Patient Monitoring Consultation Tools and Software Providers Market in Asia-Pacific, 2021-2035
10.8.4. Remote Patient Monitoring Consultation Tools and Software Providers Market in Middle-East and North Africa (MENA), 2021-2035
10.8.5. Remote Patient Monitoring Consultation Tools and Software Providers Market in Latin America, 2021-2035
11. IMPACT OF COVID-19 PANDEMIC ON DIGITAL SOLUTIONS FOR BIOMARKERS MARKET
11.1. Chapter Overview
11.2. Impact of COVID-19 on Telemedicine and Remote Patient Monitoring
11.2.1. Impact on Future Market Opportunity for Remote Patient Monitoring
11.3. Recuperative Initiatives of Key Players
11.4. Recuperative Strategies for Businesses
11.4.1. Strategies for Implementation in the Short / Mid Term
11.4.2. Strategies for Implementation in the Long Term
12. SWOT ANALYSIS
12.1. Chapter Overview
12.2. Strengths
12.3. Weaknesses
12.4. Opportunities
12.5. Threats
12.6. Comparison of SWOT Factors
13. CONCLUSION
14. INTERVIEW TRANSCRIPTS
14.1. Chapter Overview
14.2. AltumView System
14.2.1. Company Snapshot
14.2.2. Survey Transcript
15. APPENDIX I: TABULATED DATA
16. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS
Figure 3.1 Type of Telemedicine
Figure 3.2 Steps Involved in Remote Patient Monitoring
Figure 3.3 Key Benefits and Limitations of RPM Solutions
Figure 4.1 Remote Patient Monitoring Consultation Tools and Software: Distribution by Type of Software
Figure 4.2 Remote Patient Monitoring Consultation Tools and Software: Distribution by Purpose of Software
Figure 4.3 Remote Patient Monitoring Consultation Tools and Software: Distribution by Area of Application
Figure 4.4 Remote Patient Monitoring Consultation Tools and Software: Distribution by Therapeutic Area
Figure 4.5 Remote Patient Monitoring Consultation Tools and Software: Distribution by Type of Telemedicine Operation
Figure 4.6 Remote Patient Monitoring Consultation Tools and Software: Distribution by Type of Remote Patient Monitoring Service Offered
Figure 4.7 Remote Patient Monitoring Consultation Tools and Software: Distribution by Type of Business Model
Figure 4.8 Remote Patient Monitoring Consultation Tools and Software: Distribution by Year of Establishment
Figure 4.9 Remote Patient Monitoring Consultation Tools and Software: Distribution by Company Size
Figure 4.10 Remote Patient Monitoring Consultation Tools and Software: Distribution by Location of Headquarters
Figure 4.11 Most Active Players: Distribution by Number of Remote Patient Monitoring Solutions
Figure 4.12 Tree Map Representation: Distribution by Type of Software and Therapeutic Area
Figure 4.13 Stacked Bar Chart Representation: Distribution by Type of Software and Area of Application
Figure 5.1 BioTel Care: Annual Revenues, 2015-2021 (USD Million)
Figure 5.2 Masimo: Annual Revenues, 2015-2021 (USD Million)
Figure 5.3 Medtronic: Annual Revenues, 2015-2021 (USD Million)
Figure 5.4 Siemens Healthineers: Annual Revenues, 2015-2021 (USD Million)
Figure 5.5 Transtek Medical: Annual Revenues, 2015-2021 (USD Million)
Figure 6.1 Partnerships and Collaborations: Distribution by Year of Partnership
Figure 6.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 6.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Figure 6.4 Partnerships and Collaborations: Distribution by Type of Partnership and Company Size
Figure 6.5 Partnerships and Collaborations: Distribution by Type of Software
Figure 6.6 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Software
Figure 6.7 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Software
Figure 6.8 Most Active Players: Distribution by Number of Partnerships
Figure 6.9 Partnerships and Collaborations: Regional Distribution
Figure 6.10 Partnerships and Collaborations: Country-wise Distribution
Figure 6.11 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Figure 7.1 Funding and Investment Analysis: Distribution by Cumulative Year-wise Trend, 2015 - 2021
Figure 7.2 Funding and Investment Analysis: Distribution by Amount Invested (USD Million)
Figure 7.3 Funding and Investment Analysis: Distribution by Type of Funding
Figure 7.4 Funding and Investment Analysis: Distribution by Type of Venture Capital Round
Figure 7.5 Funding and Investment Analysis: Distribution by Year and Type of Funding
Figure 7.6 Funding and Investment Analysis: Distribution by Type of Funding and Amount Invested (USD Million)
Figure 7.7 Funding and Investment Analysis: Distribution by Type of Investor
Figure 7.8 Funding and Investment Analysis: Distribution by Type of Software
Figure 7.9 Funding and Investment Analysis: Distribution by Type of Software and Amount Invested (USD Million)
Figure 7.10 Funding and Investment Analysis: Distribution by Focus Area
Figure 7.11 Funding and Investment Analysis: Distribution by Geography
Figure 7.12 Funding and Investment Analysis: Distribution by Amount Invested (USD Million) and Region
Figure 7.13 Most Active Players: Distribution by Number of Instances
Figure 7.14 Most Active Players: Distribution by Amount Invested (USD Million)
Figure 7.15 Most Active Investors: Distribution by Number of Instances
Figure 7.16 Funding and Investment Analysis: Distribution by Year, Amount Invested and Type of Investor
Figure 8.1 Product Competitiveness Analysis: Software as a Service
Figure 8.2 Product Competitiveness Analysis: Software as a System
Figure 9.1 Overall Cost Saving Potential Associated with Remote Patient Monitoring Solutions, 2021-2035 (USD Million)
Figure 9.2 Cost Saving Potential Associated with Remote Patient Monitoring Solutions in North America, 2021-2035 (USD Million)
Figure 9.3 Cost Saving Potential Associated with Remote Patient Monitoring Solutions in Europe, 2021-2035 (USD Million)
Figure 9.4 Cost Saving Potential Associated with Remote Patient Monitoring Solutions in Asia-Pacific, 2021-2035 (USD Million)
Figure 9.5 Cost Saving Potential Associated with Remote Patient Monitoring Solutions in RoW, 2021-2035 (USD Million)
Figure 10.1 Global Remote Patient Monitoring Consultation Tools and Software Market, 2021-2035 (USD Million)
Figure 10.2 Remote Patient Monitoring Consultation Tools and Software Market: Distribution by Type of Area of Application, 2021 and 2035
Figure 10.3 Remote Patient Monitoring Consultation Tools and Software Market for Blood Glucose, 2021-2035 (USD Million)
Figure 10.4 Remote Patient Monitoring Consultation Tools and Software Market for Blood Pressure, 2021-2035 (USD Million)
Figure 10.5 Remote Patient Monitoring Consultation Tools and Software Market for Blood Temperature, 2021-2035 (USD Million)
Figure 10.6 Remote Patient Monitoring Consultation Tools and Software Market for ECG, 2021-2035 (USD Million)
Figure 10.7 Remote Patient Monitoring Consultation Tools and Software Market for Oxygen Saturation, 2021-2035 (USD Million)
Figure 10.8 Remote Patient Monitoring Consultation Tools and Software Market for Respiration Rate, 2021-2035 (USD Million)
Figure 10.9 Remote Patient Monitoring Consultation Tools and Software Market for Other Areas of Application, 2021-2035 (USD Million)
Figure 10.10 Remote Patient Monitoring Consultation Tools and Software Market: Distribution by Therapeutic Area, 2021 and 2035
Figure 10.11 Remote Patient Monitoring Consultation Tools and Software Market for Cardiovascular Disorders, 2021-2035 (USD Million)
Figure 10.12 Remote Patient Monitoring Consultation Tools and Software Market for Infectious Diseases, 2021-2035 (USD Million)
Figure 10.13 Remote Patient Monitoring Consultation Tools and Software Market for Metabolic Disorders, 2021-2035 (USD Million)
Figure 10.14 Remote Patient Monitoring Consultation Tools and Software Market for Oncological Disorders, 2021-2035 (USD Million)
Figure 10.15 Remote Patient Monitoring Consultation Tools and Software Market for Respiratory Disorders, 2021-2035 (USD Million)
Figure 10.16 Remote Patient Monitoring Consultation Tools and Software Market for Other Therapeutic Areas, 2021-2035 (USD Million)
Figure 10.17 Remote Patient Monitoring Consultation Tools and Software Market: Distribution by Purpose of Software, 2021 and 2035
Figure 10.18 Remote Patient Monitoring Consultation Tools and Software Market for Clinical Purpose, 2021-2035 (USD Million)
Figure 10.19 Remote Patient Monitoring Consultation Tools and Software Market for Commercial Purposes, 2021-2035 (USD Million)
Figure 10.20 Remote Patient Monitoring Consultation Tools and Software Market: Distribution by Type of Business Model, 2021 and 2035
Figure 10.21 Remote Patient Monitoring Consultation Tools and Software Market for B2B, 2021-2035 (USD Million)
Figure 10.22 Remote Patient Monitoring Consultation Tools and Software Market for B2C, 2021-2035 (USD Million)
Figure 10.23 Remote Patient Monitoring Consultation Tools and Software Market: Distribution by Geography, 2021 and 2035
Figure 10.24 Remote Patient Monitoring Consultation Tools and Software Market in North America, 2021-2035 (USD Million)
Figure 10.25 Remote Patient Monitoring Consultation Tools and Software Market in Europe, 2021-2035 (USD Million)
Figure 10.26 Remote Patient Monitoring Consultation Tools and Software Market in Asia-Pacific, 2021-2035 (USD Million)
Figure 10.27 Remote Patient Monitoring Consultation Tools and Software Market in MENA, 2021-2035 (USD Million)
Figure 10.28 Remote Patient Monitoring Consultation Tools and Software Market in Latin America, 2021-2035 (USD Million)
Figure 11.1 Remote Patient Monitoring Market, 2021-2035: COVID-19 Impact Scenario (USD Million)
Figure 11.2 Key RPM Consultation Tools and Software Providers
Figure 12.1 Remote Patient Monitoring Consultation Tools and Software Providers: SWOT Analysis
Figure 12.2 Comparison of SWOT Factors: Harvey Ball Analysis
Figure 13.1 Concluding Remarks: Current Market Landscape
Figure 13.2 Concluding Remarks: Recent Partnerships
Figure 13.3 Concluding Remarks: Funding Analysis
Figure 13.4 Concluding Remarks: Cost Saving Analysis
Figure 13.5 Concluding Remarks: Market Sizing and Opportunity Analysis
Figure 13.6 Concluding Remarks: Market Sizing and Opportunity Analysis by Geography
Table 4.1 Remote Patient Monitoring Consultation Tools and Software: Information on Status of Software Development, Approved Countries, HIPAA Compliance and Software Specification
Table 4.2 Remote Patient Monitoring Consultation Tools and Software: Information on Area of Application
Table 4.3 Remote Patient Monitoring Consultation Tools and Software: Information on Therapeutic Area
Table 4.4 Remote Patient Monitoring Consultation Tools and Software: Information on Purpose of Software and Type of Business Model
Table 4.5 Remote Patient Monitoring Consultation Tools and Software: Information on Type of Telemedicine Operation and Patient Monitoring Related Services
Table 4.6 Remote Patient Monitoring Consultation Tools and Software: Information on Year of Establishment, Company Size and Location of Headquarters
Table 5.1 BioTel Care: Company Overview
Table 5.2 BioTel Care: Software Portfolio
Table 5.3 BioTel Care: Future Outlook
Table 5.4 LeewayHertz: Company Overview
Table 5.5 LeewayHertz: Software Portfolio
Table 5.6 Masimo: Company Overview
Table 5.7 Masimo: Software Portfolio
Table 5.8 Masimo: Future Outlook
Table 5.9 Braster: Company Overview
Table 5.10 Braster: Software Portfolio
Table 5.11 LifeWatch: Company Overview
Table 5.12 LifeWatch: Software Portfolio
Table 5.13 LifeWatch: Future Outlook
Table 5.14 Medtronic: Company Overview
Table 5.15 Medtronic: Software Portfolio
Table 5.16 Medtronic: Future Outlook
Table 5.17 Siemens Healthineers: Company Overview
Table 5.18 Siemens Healthineers: Software Portfolio
Table 5.19 Siemens Healthineers: Future Outlook
Table 5.20 Transtek Medical: Company Overview
Table 5.21 Transtek Medical: Software Portfolio
Table 5.22 Transtek Medical: Future Outlook
Table 6.1 Partnerships and Collaborations: Information on Partner, Year of Partnership, Type of Partnership and Type of Software, 2015-2021
Table 7.1 Fundings and Investments: Information on Type of Funding, Year of Investment, Amount Invested and Lead Investors, 2015-2021
Table 7.2 Funding and Investment Analysis: Summary of Investments
Table 7.3 Funding and Investment Analysis: Summary of Venture Capital Round
Table 7.4 Fundings and Investments: Information on Year of Establishment, Location of Headquarters of Recipients, Software, Type of Software, and Focus Area
Table 13.1 Remote Patient Monitoring Consultation Tools and Service Providers: List of RPM Software Focused on COVID-19 Patient Monitoring
Table 13.2 Remote Patient Monitoring Consultation Tools and Service Providers: Information on Partnerships Focused on COVID-19
Table 14.1 AltumView System: Company Snapshot
Table 15.1 Remote Patient Monitoring Consultation Tools and Software: Distribution by Type of Software
Table 15.2 Remote Patient Monitoring Consultation Tools and Software: Distribution by Purpose of Software
Table 15.3 Remote Patient Monitoring Consultation Tools and Software: Distribution by Area of Application
Table 15.4 Remote Patient Monitoring Consultation Tools and Software: Distribution by Therapeutic Area
Table 15.5 Remote Patient Monitoring Consultation Tools and Software: Distribution by Type of Telemedicine Operation
Table 15.6 Remote Patient Monitoring Consultation Tools and Software: Distribution by Type of Remote Patient Monitoring Service Offered
Table 15.7 Remote Patient Monitoring Consultation Tools and Software: Distribution by Type of Business Model
Table 15.8 Remote Patient Monitoring Consultation Tools and Software: Distribution by Year of Establishment
Table 15.9 Remote Patient Monitoring Consultation Tools and Software: Distribution by Company Size
Table 15.10 Remote Patient Monitoring Consultation Tools and Software: Distribution by Location of Headquarters
Table 15.11 Most Active Players: Distribution by Number of Remote Patient Monitoring Solutions
Table 15.12 Tree Map Representation: Distribution by Type of Software and Therapeutic Area
Table 15.13 Heat Map Representation: Distribution by Type of Software and Area of Application
Table 15.14 BioTel Care: Annual Revenues, 2015-2021 (USD Million)
Table 15.15 Masimo: Annual Revenues, 2015-2021 (USD Million)
Table 15.16 LifeWatch: Annual Revenues, 2015-2021 (USD Million)
Table 15.17 Siemens Healthineers: Annual Revenues, 2015-2021 (USD Million)
Table 15.18 Transtek Medical: Annual Revenues, 2015-2021 (USD Million)
Table 15.19 Partnerships and Collaborations: Distribution by Year of Partnership
Table 15.20 Partnerships and Collaborations: Distribution by Type of Partnership
Table 15.21 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Table 15.22 Partnerships and Collaborations: Distribution by Type of Partnership and Company Size
Table 15.23 Partnerships and Collaborations: Distribution by Type of Software
Table 15.24 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Software
Table 15.25 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Software
Table 15.26 Most Active Players: Distribution by Number of Partnerships
Table 15.27 Partnerships and Collaborations: Regional Distribution
Table 15.28 Partnerships and Collaborations: Country-wise Distribution
Table 15.29 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Table 15.30 Funding and Investment Analysis: Distribution by Cumulative Year-wise Trend, 2015 - 2021
Table 15.31 Funding and Investment Analysis: Distribution by Amount Invested (USD Million)
Table 15.32 Funding and Investment Analysis: Distribution by Type of Funding
Table 15.33 Funding and Investment Analysis: Distribution by Type of Venture Capital Round
Table 15.34 Funding and Investment Analysis: Distribution by Year and Type of Funding
Table 15.35 Funding and Investment Analysis: Distribution by Type of Funding and Amount Invested (USD Million)
Table 15.36 Funding and Investment Analysis: Distribution by Type of Investor
Table 15.37 Funding and Investment Analysis: Distribution by Type of Software
Table 15.38 Funding and Investment Analysis: Distribution by Type of Software and Amount Invested (USD Million)
Table 15.39 Funding and Investment Analysis: Distribution by Focus Area
Table 15.40 Funding and Investment Analysis: Distribution by Geography
Table 15.41 Funding and Investment Analysis: Distribution by Amount Invested (USD Million) and Region
Table 15.42 Most Active Players: Distribution by Number of Instances
Table 15.43 Most Active Players: Distribution by Amount Invested (USD Million)
Table 15.44 Most Active Investors: Distribution by Number of Instances
Table 15.45 Funding and Investment Analysis: Distribution by Year, Amount Invested and Type of Investor
Table 15.46 Overall Cost Saving Potential of Using Remote Patient Monitoring Solutions, 2021-2035 (USD Million)
Table 15.47 Cost Saving Potential Associated with Remote Patient Monitoring Solutions in North America, 2021-2035 (USD Million)
Table 15.48 Cost Saving Potential Associated with Remote Patient Monitoring Solutions in Europe, 2021-2035 (USD Million)
Table 15.49 Cost Saving Potential Associated with Remote Patient Monitoring Solutions in Asia-Pacific, 2021-2035 (USD Million)
Table 15.50 Cost Saving Potential Associated with Remote Patient Monitoring Solutions in RoW, 2021-2035 (USD Million)
Table 15.51 Global Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market, 2021-2035 (USD Million)
Table 15.52 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market: Distribution by Type of Area of Application, 2021 and 2035
Table 15.53 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Blood Glucose, 2021-2035 (USD Million)
Table 15.54 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Blood Pressure, 2021-2035 (USD Million)
Table 15.55 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Blood Temperature, 2021-2035 (USD Million)
Table 15.56 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for ECG, 2021-2035 (USD Million)
Table 15.57 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Oxygen Saturation, 2021-2035 (USD Million)
Table 15.58 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Respiration Rate, 2021-2035 (USD Million)
Table 15.59 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Other Areas of Application, 2021-2035 (USD Million)
Table 15.60 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market: Distribution by Therapeutic Area, 2021 and 2035
Table 15.61 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Cardiovascular Disorders, 2021-2035 (USD Million)
Table 15.62 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Infectious Diseases, 2021-2035 (USD Million)
Table 15.63 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Metabolic Disorders, 2021-2035 (USD Million)
Table 15.64 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Oncological Disorders, 2021-2035 (USD Million)
Table 15.65 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Respiratory Disorders, 2021-2035 (USD Million)
Table 15.66 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Other Therapeutic Areas, 2021-2035 (USD Million)
Table 15.67 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market: Distribution by Purpose of Software, 2021 and 2035
Table 15.68 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Clinical Purpose, 2021-2035 (USD Million)
Table 15.69 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Commercial Purposes, 2021-2035 (USD Million)
Table 15.70 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market: Distribution by Type of Business Model, 2021 and 2035
Table 15.71 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for B2B, 2021-2035 (USD Million)
Table 15.72 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for B2C, 2021-2035 (USD Million)
Table 15.73 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market: Distribution by Geography, 2021 and 2035
Table 15.74 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market in North America, 2021-2035 (USD Million)
Table 15.75 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market in Europe, 2021-2035 (USD Million)
Table 15.76 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market in Asia-Pacific, 2021-2035 (USD Million)
Table 15.77 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market in MENA, 2021-2035 (USD Million)
Table 15.78 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market in Latin America, 2021-2035 (USD Million)
Table 15.79 Telemedicine in Remote Patient Monitoring Market, 2021-2035: COVID-19 Impact Scenario (USD Million)
Please reach out to our team for more details.